Literature DB >> 15842424

Comparison of the four formulas of adjusting QT interval for the heart rate in the middle-aged healthy Turkish men.

Abdullah Dogan1, Ercan Tunc, Ercan Varol, Mehmet Ozaydin, Mustafa Ozturk.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the QT intervals at different rest heart rates in healthy middle-aged Turkish men and to compare the known four QT adjusting methods for heart rate. METHODS AND
RESULTS: The QT intervals were measured in electrocardiograms of 210 healthy men (mean age = 35-60 years). A curve relating QT intervals and heart rates from 45 to 135 beats/min was constructed for study population. Based on the formula of Bazett, Fridericia, and Framingham, adjusted QT intervals in these range of heart rates were separately estimated. An adjusting nomogram for different heart rates was created using a reference value, which was the measured QT interval at heart rate of 60 beats/min (QT(No) = QT + correcting number). These four QT correction methods were compared with each other. The reference value of QT interval at heart rate of 60 beats/min was 382 ms. The relationship between QT and RR interval was linear (r = 0.66, P < 0.001). Nomogram method corrected QT interval most accurately for all the heart rates compared with other three adjusting methods. At heart rates of 60-100 beats/min, the equation of linear regression was QT = 237 + 0.158 x RR (P < 0.001). Bazett's formula gave the poorest results at all the heart rates. The formulas of Fridericia and Framingham were superior to Bazett's formula; however, they overestimated QT interval at heart rate of 60-110 beats/min (P < 0.01). At lower rates (<60 beats/min), all methods except nomogram method, underestimated QT interval (P = 0.03).
CONCLUSION: Among four QT correction formulas, the nomogram method provides the most accurately adjusted values of QT interval for all the heart rates in healthy men. Bazett's formula fails to adjust the QT interval for all the heart rates.

Entities:  

Mesh:

Year:  2005        PMID: 15842424      PMCID: PMC6932732          DOI: 10.1111/j.1542-474X.2005.05604.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  17 in total

Review 1.  QT interval measurements.

Authors:  Josef Kautzner
Journal:  Card Electrophysiol Rev       Date:  2002-09

2.  Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval.

Authors:  M Malik; P Färbom; V Batchvarov; K Hnatkova; A J Camm
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

3.  Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study.

Authors:  P M Okin; R B Devereux; B V Howard; R R Fabsitz; E T Lee; T K Welty
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

4.  QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability.

Authors:  Velislav N Batchvarov; Azad Ghuran; Peter Smetana; Katerina Hnatkova; Monica Harries; Polychronis Dilaveris; A John Camm; Marek Malik
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

5.  QT interval prolongation as predictor of sudden death in patients with myocardial infarction.

Authors:  P J Schwartz; S Wolf
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

6.  Diurnal variation of the QT interval--influence of the autonomic nervous system.

Authors:  R S Bexton; H O Vallin; A J Camm
Journal:  Br Heart J       Date:  1986-03

7.  QT interval prolongation predicts cardiovascular mortality in an apparently healthy population.

Authors:  E G Schouten; J M Dekker; P Meppelink; F J Kok; J P Vandenbroucke; J Pool
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

8.  An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

Authors:  A Sagie; M G Larson; R J Goldberg; J R Bengtson; D Levy
Journal:  Am J Cardiol       Date:  1992-09-15       Impact factor: 2.778

9.  The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome.

Authors:  G M Vincent; K W Timothy; M Leppert; M Keating
Journal:  N Engl J Med       Date:  1992-09-17       Impact factor: 91.245

10.  Effects of age, sex, and race on ECG interval measurements.

Authors:  P W Macfarlane; S C McLaughlin; B Devine; T F Yang
Journal:  J Electrocardiol       Date:  1994       Impact factor: 1.438

View more
  9 in total

Review 1.  Assessing QT interval prolongation and its associated risks with antipsychotics.

Authors:  Jimmi Nielsen; Claus Graff; Jørgen K Kanters; Egon Toft; David Taylor; Jonathan M Meyer
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

Review 2.  QT interval abnormalities: risk factors and perioperative management in long QT syndromes and Torsades de Pointes.

Authors:  Alan David Kaye; Jacqueline Volpi-Abadie; J Michael Bensler; Adam M Kaye; James H Diaz
Journal:  J Anesth       Date:  2013-02-15       Impact factor: 2.078

3.  Moxifloxacin Increases Heart Rate in Humans.

Authors:  Jay W Mason; Thomas E Moon
Journal:  Antibiotics (Basel)       Date:  2017-02-05

4.  QT correction using Bazett's formula remains preferable in long QT syndrome type 1 and 2.

Authors:  Pia Dahlberg; Ulla-Britt Diamant; Thomas Gilljam; Annika Rydberg; Lennart Bergfeldt
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-10-18       Impact factor: 1.468

5.  A Practical Method for QTc Interval Measurement.

Authors:  Nestor R De Oliveira Neto; William Santos De Oliveira; Guilherme D Campos Pinto; Eric Santos R De Oliveira; Maria das Neves D Da Silveira Barros
Journal:  Cureus       Date:  2020-12-17

6.  The best QT correction formula in a non-hospitalized population: the Fasa PERSIAN cohort study.

Authors:  Mohammad Hosein Yazdanpanah; Mohammad Mehdi Naghizadeh; Sepideh Sayyadipoor; Mojtaba Farjam
Journal:  BMC Cardiovasc Disord       Date:  2022-02-16       Impact factor: 2.298

7.  Cardiovascular safety of anagrelide in healthy subjects: effects of caffeine and food intake on pharmacokinetics and adverse reactions.

Authors:  Manuel Martínez-Sellés; Tomás Datino; Lourdes Figueiras-Graillet; Joubert G Gama; Christopher Jones; Richard Franklin; Francisco Fernández-Avilés
Journal:  Clin Drug Investig       Date:  2013-01       Impact factor: 2.859

8.  Which QT Correction Formulae to Use for QT Monitoring?

Authors:  Bert Vandenberk; Eline Vandael; Tomas Robyns; Joris Vandenberghe; Christophe Garweg; Veerle Foulon; Joris Ector; Rik Willems
Journal:  J Am Heart Assoc       Date:  2016-06-17       Impact factor: 5.501

9.  Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging.

Authors:  Arsalan Rafiq; Tausif Chughtai; Umair Ashraf; Yash Patel; Farbod Raiszadeh; Eduard Sklyar; Maryam Afshar; Jonathan N Bella; Gayathri Kamalakkannan
Journal:  Indian Heart J       Date:  2020-07-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.